Cardiac function in a large animal model of myocardial infarction at 7 T: deep learning based automatic segmentation increases reproducibility.

Journal: Scientific reports
PMID:

Abstract

Cardiac magnetic resonance (CMR) imaging allows precise non-invasive quantification of cardiac function. It requires reliable image segmentation for myocardial tissue. Clinically used software usually offers automatic approaches for this step. These are, however, designed for segmentation of human images obtained at clinical field strengths. They reach their limits when applied to preclinical data and ultrahigh field strength (such as CMR of pigs at 7 T). In our study, eleven animals (seven with myocardial infarction) underwent four CMR scans each. Short-axis cine stacks were acquired and used for functional cardiac analysis. End-systolic and end-diastolic images were labelled manually by two observers and inter- and intra-observer variability were assessed. Aiming to make the functional analysis faster and more reproducible, an established deep learning (DL) model for myocardial segmentation in humans was re-trained using our preclinical 7 T data (n = 772 images and labels). We then tested the model on n = 288 images. Excellent agreement in parameters of cardiac function was found between manual and DL segmentation: For ejection fraction (EF) we achieved a Pearson's r of 0.95, an Intraclass correlation coefficient (ICC) of 0.97, and a Coefficient of variability (CoV) of 6.6%. Dice scores were 0.88 for the left ventricle and 0.84 for the myocardium.

Authors

  • Alena Kollmann
    Comprehensive Heart Failure Center (CHFC), Chair of Molecular and Cellular Imaging, University Hospital Würzburg, Würzburg, Germany.
  • David Lohr
    Chair of Cellular and Molecular Imaging, Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Am Schwarzenberg 15, 97078, Würzburg, Germany.
  • Markus J Ankenbrand
    Chair of Cellular and Molecular Imaging, Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Am Schwarzenberg 15, 97078, Würzburg, Germany. markus.ankenbrand@uni-wuerzburg.de.
  • Maya Bille
    Comprehensive Heart Failure Center (CHFC), Chair of Molecular and Cellular Imaging, University Hospital Würzburg, Würzburg, Germany.
  • Maxim Terekhov
    Comprehensive Heart Failure Center (CHFC), Department of Cardiovascular Imaging, University Hospital Würzburg, Am Schwarzenberg 15, 97078, Würzburg, Germany. Terekhov_M@ukw.de.
  • Michael Hock
    Chair of Cellular and Molecular Imaging, Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Am Schwarzenberg 15, 97078, Würzburg, Germany.
  • Ibrahim Elabyad
    Comprehensive Heart Failure Center (CHFC), Chair of Molecular and Cellular Imaging, University Hospital Würzburg, Würzburg, Germany.
  • Steffen Baltes
    Comprehensive Heart Failure Center (CHFC), Chair of Molecular and Cellular Imaging, University Hospital Würzburg, Würzburg, Germany.
  • Theresa Reiter
    Chair of Cellular and Molecular Imaging, Comprehensive Heart Failure Center (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
  • Florian Schnitter
    Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
  • Wolfgang R Bauer
    Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
  • Ulrich Hofmann
    Department of Internal Medicine I / Cardiology, University Hospital Würzburg, Oberdürrbacher Straße 6, 97080, Würzburg, Germany.
  • Laura M Schreiber
    Chair of Cellular and Molecular Imaging, Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Am Schwarzenberg 15, 97078, Würzburg, Germany.